TRAIL: Treatment of Intracranial Aneurysms With LVIS® System
NCT ID: NCT02921711
Last Updated: 2025-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2012-06-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device
NCT01541254
Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support)
NCT01793792
Safety and Efficacy of the LVIS and LVIS JR Devices in the Endovascular Treatment of Intracranial Aneurysms
NCT03553771
Low-profile Visualized Intraluminal Support -HUD
NCT02695030
Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms
NCT05755516
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LVIS®
LVIS®
Low-profile Visualized Intraluminal Support device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LVIS®
Low-profile Visualized Intraluminal Support device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient has a ruptured or unruptured intracranial aneurysm for which:
* The parent artery has a diameter ≥ 2.0mm and ≤ 4.5 mm;
* The aneurysm neck size is ≥ 4mm or its dome-to-neck ratio is \< 2 (wide neck)
* Endovascular treatment with coils and one or more LVIS® devices has been determined necessary for the patient by the multidisciplinary team
3. Patient is aged ≥ 18 years
4. Patient presents with a WFNS score between 0 and 3
5. Patient has agreed to attend follow-up appointments
Exclusion Criteria
2. Patient presents with medical or surgical co-morbidities limiting his/her life expectancy to less than one year
3. Patient has a contraindication to platelet inhibition treatment
4. Patient requires retreatment of an aneurysm previously treated with a stent
5. Patient is pregnant
6. Patient has multiple aneurysms to be treated in one procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Microvention-Terumo, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charbel Mounayer, Prof.
Role: PRINCIPAL_INVESTIGATOR
CHU Limoges; Limoges, France
Michel Piotin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Fondation Rothschild; Paris, France
Related Links
Access external resources that provide additional context or updates about the study.
Safety and effectiveness of the Low Profile Visualized Intraluminal Support (LVIS and LVIS Jr) devices in the endovascular treatment of intracranial aneurysms: results of the TRAIL multicenter observational study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRAIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.